About Life Sciences Partners
Life Sciences Partners is a private equity firm founded in 1998. It is primarily based in Amsterdam, Netherlands.
Overall Life Sciences Partners portfolio has seen 18 IPOs and 54 acquisitions, namely argenx, Sequana Medical and Evommune. A lot of funds co-invest with Life Sciences Partners, with names like EQT sharing a substantial percentage of its portfolio.
Life Sciences Partners has a team of 15 people, including 8 partners.
Key Metrics
Life Sciences Partners' Portfolio
They have invested in a total of 122 companies. Their most recent investment was in Tubulis Technologies (Series B round) on Mar 14, 2024. Here is the most recent investment by Life Sciences Partners:Date | Company | Round | Amount | Co-Investors |
|---|---|---|---|---|
Mar 14, 2024 | Series B | 8577 | ||
Jan 05, 2024 | Series B | 7715 | ||
Dec 18, 2023 | Series A | 2030 | and 2 others | |
Dec 12, 2023 | Series A | 7684 |
Here is the portfolio snapshot of Life Sciences Partners:
Investments by Year
The maximum number of investments were made in 2019
Team profile of Life Sciences Partners
Life Sciences Partners has a team of 15 members including 8 Partners, 3 Venture Partners and 3 Principals located in Netherlands, Belgium and 2 more locations. Life Sciences Partners' team does not sit on the board of any company as of now.Here is a list of top team members in Life Sciences Partners:
Name | Designation | Location | Board Memberships | Contact Details |
|---|---|---|---|---|
Partner | Munich | - | ||
Partner | Netherlands | - | ||
Partner | Belgium | - | ||
Partner | Netherlands | - | ||
Partner | Netherlands | - | ||
Partner | United Kingdom | - | ||
Partner | Belgium | - | ||
Partner | Germany | - | - | |
Venture Partner | Belgium | - | ||
Venture Partner | Netherlands | - | - | |
Venture Partner | - | - | - |
Co-investors of Life Sciences Partners
Over the past 28 years, 224 investors have co-invested in Life Sciences Partners's portfolio companies.
- Top Co-investors of Life Sciences Partners: 224 investors entered a company along with Life Sciences Partners. These include investors like EQT (13 companies).
Life Sciences Partners News
•
EQT Life Sciences leads Series A funding round for maternal health company Nua SurgicalPR Newswire•Dec 06, 2024•Kidron Capital, TMC Venture Fund, EQT Ventures, NUA Surgical and 4 others
•
PanTera’s Landmark Series A Fuels Cancer FightTipRanks•Sep 11, 2024•Pantera, Life Sciences Partners, Bayer
•
Phagenesis Appoints Chad Hoskins as Chief Executive Officer Following Recent Close of $42M Series D FinancingPR Newswire•Sep 05, 2024•Phagenesis, EQT, Sectoral, British Patient Capital and 3 others
•
Asceneuron gains $100m for neurodegenerative therapeuticsPharmaceutical Technology•Jul 16, 2024•Asceneuron, Novo Holdings, EQT, Orbimed and 9 others
•
•
GÖRG advises coparion on the Series B2 financing round of TubulisRecht•Apr 05, 2024•Tubulis Technologies, GORG, Nextech Invest, Life Sciences Partners and 10 others
•
ONWARD® Medical Successfully Raises €20 Million in a Capital ...Business Insider•Mar 21, 2024•ONWARD, Inkef, EQT, Bryan, Garnier & Co and 4 others
•
Nouscom extends Series C round to $82m for cancer vaccine trialsPharmaceutical Technology•Mar 21, 2024•Nouscom, Angelini Ventures, Andera Partners, Bpifrance and 9 others
•
Tubulis GmbH’s Series B2 FinancingGlobal Legal Chronicle•Mar 19, 2024•Life Sciences Partners, Tubulis Technologies, Baker McKenzie
•
